AGILENT TECHNOLOGIES, INC. Proceeds from Issuance of Commercial Paper
AGILENT TECHNOLOGIES, INC. (A) reported Proceeds from Issuance of Commercial Paper of $1.41 billion for the 6-month period ending 2023-04-30, per its 10-Q filed 2023-05-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommercialPaper · last filed 2023-05-26
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for the quarter ending 2023-04-30 was $885.00M, a 164.18% increase year-over-year.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for the quarter ending 2023-01-31 was $527.00M, a 119.58% increase year-over-year.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for the quarter ending 2022-10-31 was $355.00M, a 129.03% increase year-over-year.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for the quarter ending 2022-07-31 was $365.00M, a 40.38% increase year-over-year.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for fiscal 2022 was $1.29B, a 21.37% decline from fiscal 2021.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for fiscal 2021 was $1.65B, a 292.14% increase from fiscal 2020.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for fiscal 2020 was $420.00M.
- AGILENT TECHNOLOGIES, INC. proceeds from issuance of commercial paper for fiscal 2019 was $0.00.
| Period end | Proceeds from Issuance of Commercial Paper 3 month | Proceeds from Issuance of Commercial Paper 6 month | Proceeds from Issuance of Commercial Paper 9 month | Proceeds from Issuance of Commercial Paper 12 month |
|---|---|---|---|---|
| 2023-04-30 | $885.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-26 | $1.41B 10-Q · filed 2023-05-26 | $1.77B derived: sum of 3 quarters · filed 2023-05-26 | $2.13B derived: sum of 4 quarters · filed 2023-05-26 |
| 2023-01-31 | $527.00M 10-Q · filed 2023-03-03 | $882.00M derived: sum of 2 quarters · filed 2023-03-03 | $1.25B derived: sum of 3 quarters · filed 2023-03-03 | $1.58B derived: sum of 4 quarters · filed 2023-05-26 |
| 2022-10-31 | $355.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $720.00M derived: sum of 2 quarters · filed 2022-12-21 | $1.05B derived: sum of 3 quarters · filed 2023-05-26 | $1.29B 10-K · filed 2022-12-21 |
| 2022-07-31 | $365.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-01 | $700.00M derived: sum of 2 quarters · filed 2023-05-26 | $940.00M 10-Q · filed 2022-09-01 | $1.09B derived: sum of 4 quarters · filed 2023-05-26 |
| 2022-04-30 | $335.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-26 | $575.00M 10-Q · filed 2023-05-26 | $730.00M derived: sum of 3 quarters · filed 2023-05-26 | $990.00M derived: sum of 4 quarters · filed 2023-05-26 |
| 2022-01-31 | $240.00M 10-Q · filed 2023-03-03 | $395.00M derived: sum of 2 quarters · filed 2023-03-03 | $655.00M derived: sum of 3 quarters · filed 2023-03-03 | $1.10B derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-10-31 | $155.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $415.00M derived: sum of 2 quarters · filed 2022-12-21 | $862.00M derived: sum of 3 quarters · filed 2022-12-21 | $1.65B 10-K · filed 2022-12-21 |
| 2021-07-31 | $260.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-01 | $707.00M derived: sum of 2 quarters · filed 2022-09-01 | $1.49B 10-Q · filed 2022-09-01 | $1.67B derived: sum of 4 quarters · filed 2022-12-21 |
| 2021-04-30 | $447.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-31 | $1.23B 10-Q · filed 2022-05-31 | $1.41B derived: sum of 3 quarters · filed 2022-12-21 | $1.65B derived: sum of 4 quarters · filed 2022-12-21 |
| 2021-01-31 | $785.00M 10-Q · filed 2022-03-03 | $965.00M derived: sum of 2 quarters · filed 2022-12-21 | $1.21B derived: sum of 3 quarters · filed 2022-12-21 | $1.21B derived: sum of 4 quarters · filed 2022-12-21 |
| 2020-10-31 | $180.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $420.00M derived: sum of 2 quarters · filed 2022-12-21 | $420.00M derived: sum of 3 quarters · filed 2022-12-21 | $420.00M 10-K · filed 2022-12-21 |
| 2020-07-31 | $240.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | $240.00M derived: sum of 2 quarters · filed 2021-09-01 | $240.00M 10-Q · filed 2021-09-01 | $240.00M derived: sum of 4 quarters · filed 2021-12-17 |
| 2020-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-01 | $0.00 10-Q · filed 2021-06-01 | $0.00 derived: sum of 3 quarters · filed 2021-12-17 | |
| 2020-01-31 | $0.00 10-Q · filed 2021-03-02 | $0.00 derived: sum of 2 quarters · filed 2021-12-17 | ||
| 2019-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-17 | $0.00 10-K · filed 2021-12-17 | ||
| 2019-07-31 | $0.00 10-Q · filed 2020-09-01 | |||
| 2018-10-31 | $0.00 10-K · filed 2020-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |